New guidance concerning the use of sodium valproate has been released by the Medicines and Healthcare Products Regulatory Agency (MHRA). It urges medical professionals to give women better information about the risks of taking the drug
The US Food and Drug Administration (FDA) is deciding whether to allow human trials of a way of making ‘designer babies’. That is, embryos made from selected genetic material and screened for conditions like epilepsy
Epilepsy Action resource for women with epilepsy has received a ‘highly commended’ award at a patient information awards ceremony. Launched earlier this year, the resource aims to make mums-to-be with epilepsy aware of issues that might affect their pregnancy
